Amount Raised
$56 Million
Round Type
Funding Round
San FranciscoBiotechnologyHealth CarePharmaceuticalBiopharmaInvestors
Description
Attralus, Inc. announced that it has closed a $56 million financing round led by new investor Alpha Wave Ventures and also included Bristol Myers Squibb (BMY). Existing investors also participated including founding investor venBio Partners, Surveyor Capital (a Citadel company), Vivo Capital, Logos Capital and Sarissa Capital Management.
Who else raised in Pharmaceutical and Biopharma around the same time
Companies in the same sectors as Attralus that raised within 45 days of this round, from Fundz verified event records.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- vTv Therapeutics Inc. raised $51M on February 27, 2024.
- OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
- AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
- LSL Pharma Group raised $6.4M (Post-IPO Equity) on March 20, 2024.
Who to call at Attralus, and when
A new round usually means Attralus is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Attralus raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Attralus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Attralus. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Attralus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Attralus raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.